Armistice Capital, LLC, Director, 10% Owner at EYEGATE PHARMACEUTICALS INC (EYEG), bought 23,000 shares at $6.04 ($140K) on 2020-02-10, disclosed to the SEC on 2020-02-10.
Open-market purchase of $140k EYEG by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.18 | 11,000 | $68K | 48.4% |
| 2 | $6.04 | 12,000 | $72K | 51.6% |
| Total | $6.11 avg | 23,000 | $140K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |